Home > Healthcare > Biotechnology > Biopharma > Cancer Stem Cells Therapy Market
Cancer Stem Cells Therapy Market Size
- Report ID: GMI7152
- Published Date: Oct 2023
- Report Format: PDF
Cancer Stem Cells Therapy Market Size
Cancer Stem Cells Therapy Market size was valued at USD 4.4 billion in 2022 and is estimated to account for USD 12 billion by 2032 due to several factors such as the increasing cases of cancer, growing private and public initiatives and rising awareness regarding availability of stem cell therapy.
For instance, according to World Health Organization (WHO), cancer was the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Therefore, there is a larger patient population in need of effective treatments. Cancer stem cells therapy refers to targeted treatments and therapeutic strategies specifically designed to identify, target, and eliminate cancer stem cells therapy (CSCs) within tumors. Cancer stem cells therapy are a subset of cells within a tumor that exhibit stem cell-like properties, including the ability to self-renew and differentiate into various cell types found in the tumor. These cells are believed to play a significant role in tumor progression, metastasis, and resistance to conventional cancer therapies.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Cancer Stem Cells Therapy Market Size in 2022: | USD 4.4 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 10.2% |
| 2032 Value Projection: | USD 12 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 120 |
| Tables, Charts & Figures: | 256 |
| Segments covered: | Type, Cancer Type, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Cancer Stem Cells Therapy Market Scope
